Consolidated Statements Of Cash Flows (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net earnings	$ 63.8		$ 94.1	$ 131.3
Adjustments to reconcile earnings to net cash provided by operating activities:
Depreciation and amortization	129.4		109.0	112.7
Write off of debt financing costs			18.9
Loss on disposal of discontinued operations	17.0		10.0	1.5
Impairment on assets of discontinued operations	11.9			18.0
Fixed and intangible asset impairments	15.8	[1]		5.2
Deferred income taxes	33.1		37.0	26.5
Share-based compensation	12.7		15.9	15.6
Equity earnings from joint venture	(65.1)		(59.4)	(55.9)
U.S. pension expense (credit)	0.6		(2.1)	(12.2)
Non-cash foreign currency translation on intercompany loans	37.2
Other, non-cash adjustments, net	(2.7)		(4.6)	(3.3)
Changes in operating assets and liabilities:
Receivables	(6.2)		(8.8)	8.8
Inventories	(26.8)		(11.9)	(0.6)
Other current assets	(9.7)		(9.2)	(10.4)
Other non-current assets	(2.9)		7.1	3.7
Accounts payable and accrued expenses	(6.1)		37.4	(23.6)
Income taxes payable	24.2		16.3	33.4
Other long-term liabilities	(21.0)		(35.3)	(27.9)
Other, net	3.6		(0.7)	(2.8)
Net cash provided by operating activities	208.8		213.7	220.0
Cash flows from investing activities:
Purchases of property, plant and equipment	(222.9)		(213.7)	(198.8)
Divestiture				24.6
Restricted cash				1.5
Return of investment from joint venture	67.9		61.1	63.5
(Payment of) proceeds from company owned life insurance, net	(0.5)		(0.4)	0.7
Proceeds from the sale of assets	7.9		7.2	16.6
Proceeds from settlement of note receivable	2.4
Net cash effect from deconsolidation of DLW	(4.1)
Net cash (used for) investing activities	(149.3)		(145.8)	(91.9)
Cash flows from financing activities:
Proceeds from revolving credit facility and other short-term debt	122.8
Payments of revolving credit facility and other short-term debt	(122.8)
Proceeds from long-term debt			1,111.0	250.0
Payments of long-term debt	(23.9)		(1,115.5)	(22.0)
Financing costs			(7.2)	(8.1)
Special dividends paid	(1.3)		(1.4)	(507.1)
Excess tax benefits from stock-based compensation	8.4
Proceeds from exercised stock options	17.8		8.6	12.2
Proceeds from company owned life insurance loans, net	2.3		2.2	1.3
Payment for treasury stock acquired			(261.4)
Net cash provided by (used for) financing activities	3.3		(263.7)	(273.7)
Effect of exchange rate changes on cash and cash equivalents	(12.7)		(5.4)	1.4
Net increase (decrease) in cash and cash equivalents	50.1		(201.2)	(144.2)
Cash and cash equivalents at beginning of year	135.2		336.4	480.6
Cash and cash equivalents at end of year	185.3		135.2	336.4
Cash and cash equivalents at end of year of discontinued operations			22.9	10.3
Cash and cash equivalents at end of year of continuing operations	185.3		112.3	326.1
Supplemental Cash Flow Disclosures:
Interest paid	40.2		42.4	47.0
Income taxes paid, net	15.0		14.4	8.4
Amounts in accounts payable for capital expenditures	$ 18.7		$ 15.3	$ 25.9

[1] Totals for 2014, 2013 and 2012 will differ from the totals on our Consolidated Statement of Cash Flow by the amounts that have been classified as discontinued operations